Categories
We’ve answered many different kinds of questions for many different organisations in over 70 countries. They include:
Universal Basic Income During the Coronavirus Pandemic
The COVID-19 Pandemic is projected to cause an economic shock larger than the Global Financial Crisis of 2007/2008 and a recession as great as anything seen since the Great Depression in 1930s. The social and economic consequences of lockdowns and social distancing measures, such as unemployment, broken relationships and homelessness create potential for inter-generational trauma extending decades into the future. In the absence of a vaccine, governments need to introduce Universal Basic Income (UBI) as a means of mitigating this trauma.
Measuring the health impact of Universal Basic Income
In 2019, we reviewed Universal Basic Income (UBI) trial design and findings in comparison with the social gradient in health literature and biopsychosocial theory to identify knowledge gaps. The findings highlight a need to refocus UBI trials on improved health, including via reduced stress, to provide policy makers the means of producing accurate cost-benefit analysis. Previous trials have either not reflected likely UBI policy or failed to measure impacts that enable accurate analysis.
The long-term health impacts of changing exposure to air pollutants in London
Transport for London (TfL) and the Greater London Authority (GLA) commissioned HealthLumen to quantify the health impacts of policies designed to reduce levels of air pollution and improve long-term health. This 2020 study estimates the number of new cases of disease and the resulting costs to the NHS and social care system under three scenarios from 2016 to 2050. The results from this study show that the ULEZ policies and broader, more all-encompassing LES policies have important impacts on the health of Londoners.
REBALANCE: Mixed-methods systematic review and economic evaluation for severe obesity
A study to systematically review bariatric surgery, weight-management programmes (WMPs) and orlistat pharmacotherapy for adults with severe obesity, and evaluate the feasibility, acceptability, clinical effectiveness and cost-effectiveness of treatment.
Obesity in primary care: Screening and brief intervention
The Brief Intervention for Weight Loss Trial enrolled consecutively attending primary care patients who were obese and participants were randomised to physicians opportunistically endorsing, offering, and facilitating a referral to a weight loss programme (support) or recommending weight loss (advice). We use a cohort simulation to predict effects on disease incidence, quality of life, and healthcare costs over 20 years.
Aiming High: Why the UK should aim to be tobacco-free
Smoking is still the biggest preventable cause of cancer in the UK, and the biggest cause of premature mortality and health inequalities. This study used a state of the art simulation model to measure dynamic changes in smoking prevalence in the UK over time by age, gender, sex and socio-economic status.